title: Clinical trial update: National Cancer Institute of Canada.
abstract: The Breast Cancer Site Group (BCSG) of the National Cancer Institute of Canada (NCIC) Clinical Trials Group (CTG) has conducted a wide variety of clinical trials focussing on large phase III trials of adjuvant chemotherapy, adjuvant hormonal therapy, and optimal delivery of adjuvant radiation therapy. The Group has also fostered, together with the NCIC CTG Investigational New Drug (IND) Program, a series of phase II and phase I/II studies which will be carried through if possible, into the phase III setting.
authors.affiliation: Toronto Sunnybrook Regional Cancer Centre. kathy.pritchard@sw.ca
authors.forename: Kathy
authors.initials: K
authors.lastname: Pritchard
authors.forename: Tim
authors.initials: T
authors.lastname: Whelan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D002170:Canada; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D018714:Radiotherapy, Adjuvant
references.citation: Lancet. 2002 Jun 22;359(9324):2131-9
references.pmid: 12090977
references.citation: Cancer. 2003 Nov 1;98(9):1802-10
references.pmid: 14584060
references.citation: N Engl J Med. 2003 Nov 6;349(19):1793-802
references.pmid: 14551341
references.citation: Int J Cancer. 1999 Sep 9;82(6):893-900
references.pmid: 10446459
references.citation: J Clin Oncol. 1996 Feb;14(2):422-8
references.pmid: 8636752
references.citation: N Engl J Med. 1997 Oct 2;337(14):949-55
references.pmid: 9395428
references.citation: N Engl J Med. 1997 Oct 2;337(14):956-62
references.pmid: 9309100
references.citation: N Engl J Med. 2004 Mar 11;350(11):1081-92
references.pmid: 15014181